2024-07-23 at 3DTE
T Jul 26th 16/17 Put Ratio Spread
Options Overlay indicator and Options Screener in action.
Tomorrow before open : Earnings
Max loss: $2.5
Max profit: $97
Bp.req: $200
Bearish micro, bullish macro.
I expect that even in the event of a possible fall, the 4/8 will hold the price.
If it doesn't, then the upward macro trend.
So I went for a pretty safe-looking trade, with the green rage showing the range of returns, so I will sleep well :)
PUTS = CALLS equally priced for 3DTE.
T Jul 26th 16/17 Put Ratio SpreadOptions Overlay indicator and Options Screener in action.
Tomorrow before open : Earnings
Max loss: $2.5
Max profit: $97
Bp.req: $200
Bearish micro, bullish macro.
I expect that even in the event of a possible fall, the 4/8 will hold the price.
If it doesn't, then the upward macro trend.
So I went for a pretty safe-looking trade, with the green rage showing the range of returns, so I will sleep well :)
PUTS = CALLS equally priced for 3DTE.
Note
Boost up your charts with Options PRO!
REAL Options metrics for over 165+ liquid US symbols:
✔ 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗶𝗻𝗴 𝗚𝗘𝗫 𝗹𝗲𝘃𝗲𝗹𝘀
✔ IVRank ✔ CALL/PUT skew ✔ Volatility Skew ✔ Delta curves
👉 7-day TRIAL 🌐 TanukiTrade.com
REAL Options metrics for over 165+ liquid US symbols:
✔ 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗶𝗻𝗴 𝗚𝗘𝗫 𝗹𝗲𝘃𝗲𝗹𝘀
✔ IVRank ✔ CALL/PUT skew ✔ Volatility Skew ✔ Delta curves
👉 7-day TRIAL 🌐 TanukiTrade.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Boost up your charts with Options PRO!
REAL Options metrics for over 165+ liquid US symbols:
✔ 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗶𝗻𝗴 𝗚𝗘𝗫 𝗹𝗲𝘃𝗲𝗹𝘀
✔ IVRank ✔ CALL/PUT skew ✔ Volatility Skew ✔ Delta curves
👉 7-day TRIAL 🌐 TanukiTrade.com
REAL Options metrics for over 165+ liquid US symbols:
✔ 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗶𝗻𝗴 𝗚𝗘𝗫 𝗹𝗲𝘃𝗲𝗹𝘀
✔ IVRank ✔ CALL/PUT skew ✔ Volatility Skew ✔ Delta curves
👉 7-day TRIAL 🌐 TanukiTrade.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.